Literature DB >> 16696849

Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction.

Minoru Narita1, Naoko Kuzumaki, Michiko Narita, Chihiro Kaneko, Nana Hareyama, Mayumi Miyatake, Keiko Shindo, Kan Miyoshi, Mayumi Nakajima, Yasuyuki Nagumo, Fumiaki Sato, Hiroshi Wachi, Yoshiyuki Seyama, Tsutomu Suzuki.   

Abstract

It has been widely recognized that chronic pain could cause physiological changes at supraspinal levels. The delta-opioidergic system is involved in antinociception, emotionality, immune response and neuron-glia communication. In this study, we show that mice with chronic pain exhibit anxiety-like behavior and an increase of astrocytes in the cingulate cortex due to the dysfunction of cortical delta-opioid receptor systems. Using neural stem cells cultured from the mouse embryonic forebrain, astrocyte differentiation was clearly observed following long-term exposure to the selective delta-opioid receptor antagonist, naltrindole. We also found that micro-injection of either activated astrocyte or astrocyte-conditioned medium into the cingulate cortex of mice aggravated the expression of anxiety-like behavior. Our results indicate that the chronic pain process promotes astrogliosis in the cingulate cortex through the dysfunction of cortical delta-opioid receptors. This phenomenon may lead to emotional disorders including aggravated anxiety under chronic pain-like state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696849     DOI: 10.1111/j.1471-4159.2006.03824.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

1.  Spatiotemporal pattern of concurrent spinal and supraspinal NF-κB expression after peripheral nerve injury.

Authors:  Chiu-Wen Chou; Gordon T C Wong; Grewo Lim; Shuxing Wang; Michael G Irwin; Jianren Mao
Journal:  J Pain       Date:  2010-05-26       Impact factor: 5.820

Review 2.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Spatial and temporal plasticity of synaptic organization in anterior cingulate cortex following peripheral inflammatory pain: multi-electrode array recordings in rats.

Authors:  Yun-Fei Lu; Yan Wang; Ying He; Fu-Kang Zhang; Ting He; Rui-Rui Wang; Xue-Feng Chen; Fei Yang; Ke-Rui Gong; Jun Chen
Journal:  Neurosci Bull       Date:  2013-05-18       Impact factor: 5.203

5.  The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.

Authors:  Gary S Wand; Elise M Weerts; Hiroto Kuwabara; Dean F Wong; Xiaoqiang Xu; Mary E McCaul
Journal:  Addict Biol       Date:  2012-01-20       Impact factor: 4.280

Review 6.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 7.  Glial-neuronal interactions--implications for plasticity and drug addiction.

Authors:  Sukumar Vijayaraghavan
Journal:  AAPS J       Date:  2009-02-24       Impact factor: 4.009

Review 8.  Cerebral cortex modulation of pain.

Authors:  Yu-feng Xie; Fu-quan Huo; Jing-shi Tang
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

Review 9.  Cognitive and emotional control of pain and its disruption in chronic pain.

Authors:  M Catherine Bushnell; Marta Ceko; Lucie A Low
Journal:  Nat Rev Neurosci       Date:  2013-05-30       Impact factor: 34.870

10.  MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain.

Authors:  David A Seminowicz; Audrey L Laferriere; Magali Millecamps; Jon S C Yu; Terence J Coderre; M Catherine Bushnell
Journal:  Neuroimage       Date:  2009-06-01       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.